Teva pharmaceuticals has issued a voluntary recall of one lot of its reflux medication after discovering that bottles contained tablets of a drug used to treat fluid retention. The recall affects lot ...

Extended-release clonidine (Kapvay) is an oral drug used to treat ADHD. Learn how it works, its side effects, drug interactions, and more.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) announced today that its investigational drug TEV-53408 has received Fast Track designation from the US Food and Drug Administration (FDA) for ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) announced $16.5 billion in revenue for the fourth quarter of 2024, a 9% year-over-year gain. Adjusted EBITDA also increased by 9%, and non-GAAP ...

It had 2024 sales in the U.S. of $4.77 billion, according to Regeneron. Teva and Alvotech began a strategic partnership in August 2020 to collaborate in the U.S. biosimilar drug market.

Teva Pharmaceuticals challenges the Inflation Reduction Act, arguing CMS's drug pricing policies harm generics, biosimilars, and innovation, disrupting healthcare balance.

Treatment With SNY-TEVA Drug Exhibits Best-in-Class Potential In the UC group, 36.2% of patients who received a low dose of the drug and 47.8% of patients who received a high dose achieved ...

In the 14-week phase 2b study by Sanofi and Teva's U.S. affiliate held in the U.S., Europe and Israel, the drug, called duvakitug, showed that 36.2% of low dose and 47.8% of high dose patients ...

The European Commission has fined Israeli drugmaker Teva (TEVA) $500M for disparaging a rival product to its blockbuster multiple sclerosis drug Copaxone. Read more here.